查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386463

左心耳封堵器市场报告：2030 年趋势、预测与竞争分析

Left Atrial Appendage Closure Devices Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

左心耳封堵器的趋势与预测

预计到 2030 年，全球左心耳封堵器市场将达到 38 亿美元，2024 年至 2030 年年复合成长率为 17.7%。这个市场的主要驱动因素是心房颤动 (AF) 病例的增加、最尖端科技的日益采用以及全球生活方式的紊乱。全球左心耳封堵器市场的未来充满希望，医院和门诊手术中心市场充满机会。

左心耳封堵器市场洞察

Lucintel 预测，在预测期内，心内膜将继续占据更大的份额，因为它将用于併发症更少、住院时间更短、30 天再入院次数更少的患者。

由于对左心房颤动 (LAA) 手术的偏好不断增加以及医院对左心房颤动封堵装置的接受度不断提高，医院将继续成为该市场的最大细分市场。

由于心房颤动的增加和高龄化，北美仍然是最大的市场。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球左心耳封堵器市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球左心耳封堵器市场趋势（2018-2023）与预测（2024-2030）
  • 全球左心耳封堵器市场（按产品）
    • 心外膜
    • 心内膜
  • 全球左心耳封堵器市场（依最终用途）
    • 医院
    • 门诊手术中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球左心耳封堵器市场区域分布
  • 北美左心耳封堵器市场
  • 欧洲左心耳封堵器市场
  • 亚太地区左心耳封堵器市场
  • 其他地区左心耳封堵器市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球左心耳封堵器市场成长机会（按产品）
    • 全球左心耳封堵器市场成长机会（依最终用途）
    • 全球左心耳封堵器市场成长机会（按地区）
  • 全球左心耳封堵器市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球左心耳封堵器市场产能扩张
    • 全球左心耳封堵器械市场的合併、收购及合资企业
    • 认证和许可

第7章主要企业概况

  • Abbott Laboratories
  • AtriCure
  • Johnson & Johnson
  • Aegis Medical
  • Cardia
  • Biosense Webster
  • Sentreheart
  • Occlutech
  • Boston Scientific Corporation
  • Lifetech Scientific Corporation
简介目录

Left Atrial Appendage Closure Devices Trends and Forecast

The future of the global left atrial appendage closure devices market looks promising with opportunities in the hospitals and ambulatory surgery centers markets. The global left atrial appendage closure devices market is expected to reach an estimated $3.8 billion by 2030 with a CAGR of 17.7% from 2024 to 2030. The major drivers for this market are growing cases of atrial fibrillation (AF), increasing adoption of cutting-edge technologies, and disrupted lifestyle behaviors across the globe.

A more than 150-page report is developed to help in your business decisions.

Left Atrial Appendage Closure Devices by Segment

The study includes a forecast for the global left atrial appendage closure devices by product, end use, and region.

Left Atrial Appendage Closure Devices Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Epicardial
  • Endocardial

Left Atrial Appendage Closure Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Left Atrial Appendage Closure Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Left Atrial Appendage Closure Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies left atrial appendage closure devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the left atrial appendage closure devices companies profiled in this report include-

  • Abbott Laboratories
  • Atricure
  • Johnson & Johnson
  • Aegis Medical
  • Cardia
  • Biosense Webster
  • Sentreheart
  • Occlutech
  • Boston Scientific Corporation
  • Lifetech Scientific Corporation

Left Atrial Appendage Closure Devices Market Insights

Lucintel forecasts that endocardial will remain the larger segment over the forecast period as it is used in patients featured lower complications, shorter hospital stays, and fewer 30-day readmissions.

Within this market, hospitals will remain the largest segment due to growing preference for left atrial appendage (LAA) procedures and an increase in hospital acceptance of left atrial appendage closure devices.

North America iwill remain the largest region due to rising incidences of atrial fibrillation and increasing aging population in the region.

Features of the Global Left Atrial Appendage Closure Devices Market

Market Size Estimates: Left atrial appendage closure devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Left atrial appendage closure devices market size by product, end use, and region in terms of value ($B).

Regional Analysis: Left atrial appendage closure devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, end uses, and regions for the left atrial appendage closure devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the left atrial appendage closure devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the left atrial appendage closure devices market size?

Answer: The global left atrial appendage closure devices market is expected to reach an estimated $3.8 billion by 2030.

Q.2 What is the growth forecast for left atrial appendage closure devices market?

Answer: The global left atrial appendage closure devices market is expected to grow with a CAGR of 17.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the left atrial appendage closure devices market?

Answer: The major drivers for this market are growing cases of atrial fibrillation (AF), increasing adoption of cutting-edge technologies, and disrupted lifestyle behaviors across the globe.

Q4. What are the major segments for left atrial appendage closure devices market?

Answer: The future of the left atrial appendage closure devices market looks promising with opportunities in the hospital and ambulatory surgery center markets.

Q5. Who are the key left atrial appendage closure devices market companies?

Answer: Some of the key left atrial appendage closure devices companies are as follows:

  • Abbott Laboratories
  • AtriCure
  • Johnson & Johnson
  • Aegis Medical
  • Cardia
  • Biosense Webster
  • Sentreheart
  • Occlutech
  • Boston Scientific Corporation
  • Lifetech Scientific Corporation

Q6. Which left atrial appendage closure devices market segment will be the largest in future?

Answer: Lucintel forecasts that endocardial will remain the larger segment over the forecast period as it is used in patients featured lower complications, shorter hospital stays, and fewer 30-day readmissions.

Q7. In left atrial appendage closure devices market, which region is expected to be the largest in next 5 years?

Answer: North America iwill remain the largest region due to rising incidences of atrial fibrillation and increasing aging population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the left atrial appendage closure devices market by type (epicardial and endocardial), end use (hospitals, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Left Atrial Appendage Closure Devices Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Left Atrial Appendage Closure Devices Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Left Atrial Appendage Closure Devices Market by Product
    • 3.3.1: Epicardial
    • 3.3.2: Endocardial
  • 3.4: Global Left Atrial Appendage Closure Devices Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Ambulatory Surgery Centers
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Left Atrial Appendage Closure Devices Market by Region
  • 4.2: North American Left Atrial Appendage Closure Devices Market
    • 4.2.1: North American Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
    • 4.2.2: North American Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.3: European Left Atrial Appendage Closure Devices Market
    • 4.3.1: European Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
    • 4.3.2: European Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.4: APAC Left Atrial Appendage Closure Devices Market
    • 4.4.1: APAC Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
    • 4.4.2: APAC Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.5: ROW Left Atrial Appendage Closure Devices Market
    • 4.5.1: ROW Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
    • 4.5.2: ROW Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by Product
    • 6.1.2: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by End Use
    • 6.1.3: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by Region
  • 6.2: Emerging Trends in the Global Left Atrial Appendage Closure Devices Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Left Atrial Appendage Closure Devices Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Left Atrial Appendage Closure Devices Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: AtriCure
  • 7.3: Johnson & Johnson
  • 7.4: Aegis Medical
  • 7.5: Cardia
  • 7.6: Biosense Webster
  • 7.7: Sentreheart
  • 7.8: Occlutech
  • 7.9: Boston Scientific Corporation
  • 7.10: Lifetech Scientific Corporation